Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sight Sciences Inc
(NQ:
SGHT
)
5.790
-0.160 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sight Sciences Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 12, 2023
Via
Benzinga
Glaucoma Player Sight Sciences Stock Falls More Than 30%: Analyst Warns Of Lingering Concerns Over Coverage
September 12, 2023
Sight Sciences Inc (NASDAQ: SGHT) shares are trading lower after the company issued third-quarter total revenue guidance below estimates and cut full-year 2023 revenue
Via
Benzinga
Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday
September 12, 2023
RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT...
Via
Benzinga
Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
September 12, 2023
Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday.
Via
Benzinga
What 6 Analyst Ratings Have To Say About Sight Sciences
August 21, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Analyst Expectations for Sight Sciences's Future
July 11, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 12, 2023
It's time to start the day off with a breakdown of the biggest pre-market stock movers worth watching on Tuesday morning!
Via
InvestorPlace
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 12, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 11, 2023
Via
Benzinga
Why Sight Sciences Stock Traded Lower Today
September 11, 2023
Sight Sciences, Inc. (NASDAQ: SGHT) shares traded lower Monday after the company issued third-quarter total revenue guidance below estimates and cut full-year 2023 revenue
Via
Benzinga
Recap: Sight Sciences Q1 Earnings
May 04, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
Via
Benzinga
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 21, 2023
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
Via
Benzinga
Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On Friday
July 21, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 90 points on Friday. Here are some big stocks recording gains in today’s session. Digital World Acquisition Corp. (NASDAQ: DWAC) climbed 69%...
Via
Benzinga
Sight Sciences' TearCare Surpasses Restasis Dry Eye Treatment, Trial Data shows
July 20, 2023
Sight Sciences Inc (NASDAQ: SGHT) released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis
Via
Benzinga
Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst
July 19, 2023
Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 10, 2023
July 10, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023
July 11, 2023
Via
Benzinga
BlackRock To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday
July 10, 2023
Keybanc raised the price target for BILL Holdings, Inc. (NYSE: BILL) from $110 to $140. Keybanc analyst Josh Beck maintained an Overweight rating. BILL Holdings shares fell 2.3% to $113.00 in...
Via
Benzinga
Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)
June 21, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
June 02, 2023
Via
Benzinga
Sight Sciences' Cataract Surgery Tech Shows Consistent Lowering Of Eye Pressure, Medication Use
May 23, 2023
Sight Sciences Inc (NASDAQ: SGHT) published two-year results of the so-called "Romeo" study of the OMNI Surgical System.
Via
Benzinga
Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical
May 23, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 02, 2023
Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 08, 2023
Via
Benzinga
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
May 06, 2023
Patients undergoing procedures enabled with OMNI® Surgical System technology experienced a greater average reduction in IOP-lowering medication usage compared to other MIGS procedures or cataract...
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023
May 04, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
May 01, 2023
Clinical data includes long-term trial results and robust real-world comparative data from IRIS® Registry
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences to Present at the Upcoming Bank of America Securities 2023 Health Care Conference
April 26, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.